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Advancements in Neuroscience

Meet our providers
Junaid Kalia, MD, aims to
provide timely, evidencebased, cost-effective
acute and critical care
to neurological and
neurosurgical patients.

Dr. Kalia earned his medical degree at Sindh Medical
College, Karachi University, Karachi, Pakistan. He
completed his residency in Neurology at Saint Louis
University Hospital in Missouri and his fellowship in
Neurocritical Care at UT Southwestern Medical Center,
Dallas TX.

Dr. Kalia provides treatment
for patients suffering from
acute ischemic stroke,
intracerebral hemorrhage,
status epilepticus,
subarachnoid hemorrhage
and neuromuscular
emergencies. He has
additional training in
reading continuous
electroencephalograph (EEG)
in critically ill patients.

In his free time, Dr. Kalia enjoys spending time with
his family, technology, electronic medical records
implementation, mobile applications and racquetball.

Dr. Khan, diagnoses, treats
and manages patients
with brain and spinal cord
disorders, as well as tumors
and systemic cancers
with brain and spinal cord
complications. He brings
new therapeutic approaches
to improve outcomes and
decrease side effects and
complications.

and completed his residency at the University of Texas in
Houston. He completed fellowships in both Hematology/
Oncology and Neuro-Oncology at MD Anderson Cancer
Center, Houston, Texas. Dr. Khan has additional training
in Adult Neuro-Oncology and Pediatric Neuro-Oncology,
and is dual board-certified in Hematology/Oncology and
Neuro-Oncology.

Dr. Khan earned his medical
degree at Aga Khan
University, Karachi, Pakistan,

Elizabeth Traynor, MD,
believes in treating her
patients with the utmost
respect, helping them recover
to the best of her ability. She
provides general neurology
and stroke care.
Dr. Traynor earned her
medical degrees at The
University of Wisconsin–
Madison and Boston
University School of Medicine
in Massachusetts. She
completed her residency at
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Aurora St. Luke’s Medical Center
2900 W. Oklahoma Avenue
Milwaukee, WI 53215 • 414-649-6000
Aurora Neuroscience Innovation Institute
2801 W. Kinnickinnic River Pkwy, Suite 630
Milwaukee, WI 53215 • 414-385-7115

In his free time, Dr. Khan enjoys skiing, snowboarding,
scuba diving, reading and writing.
Aurora Cancer Care
2801 W. Kinnickinnic River Parkway Suite 930
Milwaukee, WI 53215 • 414-384-5111

Wilford Hall USAF Medical Center in San Antonio, Texas,
and is board-certified in Adult Neurology and Neurology
by the American Board of Psychiatry and Neurology.
In her free time, Dr. Traynor enjoys sewing and reading
science fiction novels. ■
Aurora Center for Epilepsy & Neurology
2801 W. Kinnickinnic River Pkwy Suite 550
Milwaukee, WI 53215 • 414-385-8780
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Thomas Wolfe, MD, is an
endovascular neurologist
that performs catheter
angiography, embolization,
embolectomy, angioplasty,
stenting and interventional
treatments and provides care
for patients with aneurysm,
AVM, ischemic stroke, brain
injury and concussion.
Dr. Wolfe earned his medical
degree at the Medical
College of Wisconsin and
completed both his residency
in Neurology and fellowship in Neurocritical Care and
Endovascular Surgical Neuroradiology at the Medical
College of Wisconsin Affiliated Hospitals, Milwaukee. He is
board-certified by the American Board of Psychiatry and
Neurology-General Neurology, Vascular Neurology and
is certified in Neurocritical Care by the United Council of
Neurological Subspecialties.

Two new stroke trials (DAWN and Defuse 3) are
revolutionizing the care Dr. Wolfe provides for stroke
patients. Prior to these studies, many patients were only
eligible for advanced stroke treatments within 6 hours of
the onset of their symptoms. Now, that treatment window
has expanded to upwards of 24 hours. With Dr. Wolfe’s
leadership, the practice of stroke at Aurora St. Luke’s
has changed and the team has heavily influenced the
development of a new EMS triage protocol in Milwaukee
County. Earlier this year, they adopted the stroke team’s
SNO scale for triage, which helps identify large vessel
occlusions and ultimately helps determine which hospital
the patient should be transferred to. This new process
shifts the focus to Right Hospital First Time for more
timely treatment.
Aurora Neuroscience Innovation Institute
2845 2801 W. Kinnickinnic River Pkwy Suite 630
Milwaukee, WI 53215 • 414-385-7113

How doctors at Aurora Medical Center in Summit gave Judy
her mobility and life back
Judy Henning has had back pain for years. At the age of
74, she just figured it’s something you live with as you
get older. But in the last year, as it began to worsen and
affect her mobility, she made an appointment with Ofer
Zikel, MD, a neurosurgeon at Aurora Medical Center
in Summit.
“What I liked about him is he didn’t try to pressure me
into surgery right away. I wanted to try physical therapy
and he agreed I should try it first, but warned me the
problem would only get worse. And he was right,”
Judy explains.
The physical therapy did make her back feel stronger;
but this past July, after moving apartments, Judy woke
up one morning and couldn’t walk.
“I had sciatica-type pain; it was shooting down my leg.
I couldn’t even walk into the hospital when I went to
see Dr. Zikel again, it was so bad,” she says. Judy was
diagnosed with spinal stenosis and this time she agreed
surgery was the best way to go.
“Spinal stenosis is a very common condition where
the spinal column becomes narrowed over time due to
degenerative changes. She was experiencing severe,
radiating leg pain due to the compression of her spinal
nerves,” Dr. Zikel explains. He performed a common
procedure to remove some of the bone and ligament
that was pressing against Judy’s nerves along her spine.

Judy says the relief was instantaneous, “Let me tell you,
that did it! I woke up after surgery and that shooting
pain was gone.”

Spinal stenosis is a very
common condition where
the spinal column becomes
narrowed over time due to
degenerative changes.

Within three weeks Judy was able to walk a mile. She
now walks a mile every single day, sometimes two. She
is incredibly grateful for Dr. Zikel and the staff at Aurora
Medical Center in Summit for not only helping her regain
her mobility, but for helping her feel safe and comforted
every step of the way.
“The staff is so superior, every single one of them. And
Dr. Zikel is just so competent. I always knew I was in such
good hands,” she says. ■
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Concussions: They don’t just happen to athletes

Stephen R. Peterson, MD
We’ve heard a lot about concussions in the world
of sports, but concussions can happen to anyone. A
concussion is not just a sports injury.
A concussion is a traumatic brain injury (TBI) that
changes the brain’s normal functions. The most
common cause of concussions is slips and falls.
Other common causes of a TBI or concussion are car
accidents or bumps, blows or jolts to the head, such
as something falling on you while working around the
home or on the job.
The Centers for Disease Control and Prevention
estimate that each year about 1.7 million emergency
department visits, hospitalizations or deaths are
associated with traumatic brain injuries.
Fortunately, most concussions cause only mild,
temporary problems. Most people recover fully.
However, an unrecognized or poorly treated concussion
can prolong the recovery time and increase the risk of
brain swelling, which can be dangerous.
Having had a previous concussion increases the risk of
another concussion.
4

What Are the Signs and Symptoms of a Concussion?
With a concussion, you may not see all of these signs
and symptoms, but if you have concerns, it’s important
to promptly seek professional health care. Some signs,
such as behavior or personality changes, may take
some time to be noticed.
Concussion signs
• Vacant stare
• Delayed verbal and/or motor responses
• Confusion and/or inability to focus attention
• Slurred or incoherent speech
• Lack of coordination
• Behavior or personality changes
• Memory deficits or amnesia
• Any loss of consciousness

Edition 4 • June 2018
Concussion symptoms

Steps to Prevent TBI

• Headache

Every sport or activity has specific steps that can
be taken to reduce the risk of TBI/concussion.
General recommendations include:

• Dizziness
• Nausea or vomiting
• Vision problems
• Hearing problems/ringing
in ears
• “Foggy” or
“slowed-down” feeling
• Drowsiness
• Increased/abnormal
emotional responses
• Difficulty concentrating
• Confusion
• Irritability
• Sensitivity to light or noise
• Difficulty remembering

• Wear the proper helmet for your activity.
• Helmets should be worn consistently and correctly.
• Helmets should be well maintained, age-appropriate
and appropriately certified for their use.
• Children should not use a helmet that’s too big
for them.
• Make sure the helmet is positioned correctly on
the head. (Bicycle helmets are commonly
worn incorrectly.)

A health care professional can properly diagnose
a concussion.
Treatment for a Concussion
A primary treatment for a concussion is rest—both
physical and mental—so the body can heal properly.
During treatment, patients may be asked to:
• Rest as long as recommended by the health
care professional.
• Avoid certain medicines. Check with a health care
professional before taking medications, especially
aspirin, blood thinners and medications that can
cause drowsiness.
• Avoid using alcohol and illegal drugs.
• Prevent re-injury by avoiding activities that might
jolt or jar the head.
• Wait to return to a sports activity until your health
care professional has given permission. Ask when it’s
safe to drive a car, ride a bike, work or play at
heights or use heavy equipment.
• Have neuropsychological testing. Check on the
availability of concussion baseline screenings and
post-concussion assessment tools.
The health care professional will likely check the
patient two or three times each week for about six to
eight weeks.

• Instruct sports participants on how to reduce their
risks for TBI and how to protect others.
• Ensure all participants understand the signs and
symptoms of a concussion and the importance
of reporting symptoms of a possible concussion to
coaches or another adult.
Around the home or workplace:
• Reduce the risks for slips and falls by ensuring
there’s good lighting and no obstructions in walking
paths. (Wrinkled rugs or carpeting, low drawers left
open and clutter on the floor are common causes
of falls.)
• Reduce wet or slippery surfaces. Potential slip-and
fall hazards include wet floors in areas such as the
bathroom or winter ice on walking paths.
If you ever have a concern or question about TBI/
concussion, check with your health care professional.
Appropriate treatment is the key to a full recovery from
a TBI/concussion. ■
5

Advancements in Neuroscience

Research
Clinical Trials
• Dabigatran Etexilate for Secondary Stroke Prevention
in Patients With Embolic Stroke of Undetermined
Source (RE-SPECT ESUS)
• Clinical trials identifier: NCT02239120
• Local PI: Ziad Darkhabani, MD
• Sponsor: Boehringer Ingelheim
• Phase: III
•
		
		
		
		
		
		

Details: This trial will randomize about 6,000
patients with recent embolic stroke of unknown
source to receive either the blood thinner dabigatran
and an aspirin placebo or aspirin and a dabigatran
placebo. Participants will be monitored every three
months for adverse and serious adverse events
and outcomes.

• Screening for Large Vessel Occlusion in Acute Ischemic
Stroke: Development and Validation of a Risk
Score Model
• Local PI: Kessarin Panichpisal, MD
• Sponsor/Collaborator: Aurora Health Care
• Type: prospective, consecutive cohort study
•
		
		
		
		
		
		
		
		

Details: This trial will test a screening tool developed
by Dr. Panichpisal to determine if three indicators
gaze deviation, expressive aphasia (inability to talk
or neglect—can identify patients experiencing an
acute stroke caused by a blockage in a large vessel.
If these signs prove to be reliable indicators of a
large-vessel occlusion-caused stroke, clinicians will
be able to expedite prompt and effective medical
intervention for these patients in the future.

For the fourth year in a row, the National Cancer Institute
(NCI) has increased the grant allotment to Aurora NCORP,
bringing the four-year grant total to $3,413,327. Aurora,
which started its fourth year of participation in NCORP in
2017, is projected to receive more than $4 million by the
time its five-year NCORP grant cycle ends in 2019.
Aurora is one of 34 sites nationwide participating in
NCORP, which brings clinical cancer trials to people in
their own communities instead of only at major research
institutions. Conducting clinical trials in a range of
communities small and large means a more diverse patient
population can participate in clinical trials in “real-world”
health care settings. This expanded access to clinical trials,
in turn, generates more broadly applicable evidence that
contributes to improved patient outcomes and a reduction
in cancer disparities.
Currently, Aurora NCORP has about 50 NCI clinical trials
open to recruitment for multiple cancer types, including
brain, breast, lung and prostate cancers, as well as
leukemia, lymphoma and melanoma. These clinical
trials are available at nearly all 20 Aurora Health Care
cancer clinics. ■

Help for headache sufferers
Dr. Shawn Witton
Marinette Eagle Herald
Headaches, especially migraines, can be a real pain. Most
people suffer from headaches occasionally, but when
the situation becomes chronic and debilitating or limits
one’s ability to enjoy life, it’s time to seek medical help.
Migraines affect more than 37 million people, or about
13 percent of American adults. More women than men
suffer from them. And for as many as two to three
million migraine sufferers, migraine headaches
become a chronic problem.
6

In addition to migraine headaches, there are other
types of headaches, such as cluster headaches, tension
headaches and sinus headaches. You may wonder what
the difference is between a “regular” headache and a
migraine headache.
Some people who think they have a sinus headache may
actually have a migraine. Sinus headaches and migraines
share some symptoms in common, including:
• Pain in the head, particularly the forehead
• Itchy or watery eyes
• Pain when you move
continued on next page
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Headache sufferers continued
Migraine sufferers may also experience:
• Nausea

• Sensitivity to sound

• Vomiting

• Sensitivity to light

• A long-duration headache—a migraine can last from
four hours to three days or more
• Severe throbbing pain on one side of the head
Many factors can trigger migraine headaches, including
lack of food or sleep, exposure to environmental or foodrelated triggers, weather changes, stress or anxiety and
hormonal swings in women.
If you do get headaches often, try to become aware of
what triggers them and avoid those situations if possible.
While there is currently no permanent cure for migraines,
there are many ways to manage the severity and
frequency of attacks. Medications can be used to reduce
or stop the pain once an attack has started.
If you suffer from migraines, chances are you may
have been treated with acetaminophen (Tylenol),
NSAIDS (non-steroidal anti-inflammatory drugs such as
ibuprofen or naproxen), triptans (serotonin activators
such as sumatriptan/Imitrex) or anti-nausea meds. Your
health care provider may have prescribed additional
medications as well. All these remedies work best when
given at the earliest signs of migraine onset.

While prescriptions may work well for you, they can
have side effects. Consider treating your migraines
using holistic, non-drug approaches, such as limiting
stress through yoga, Tai Chi or acupuncture. This ancient
Chinese medicine technique, where fine needles are
inserted into specific points in the body, has been shown
to decrease frequency and intensity of headaches for
some people.
Addressing the problem of frequent or severe headaches
is important in improving a person’s quality of life.
Frequent headaches should also be treated because they
may signal potentially serious health problems, including
depression, sinus infection, high blood pressure, sleep
apnea or even a stroke, brain infection or cancer.
If you experience a new, severe or constant headache
that begins suddenly and is accompanied by weakness,
dizziness, numbness or other strange physical
sensations, please seek medical attention immediately.
If you have concerns about your headaches, please
consult with your health care professional, who can refer
you to a specialist if needed.

In addition to medications, some proactive steps
migraine sufferers can take to reduce the frequency or
intensity of their migraines include:
• Increasing your daily intake of water
• Not smoking, or quitting smoking
• Sticking to a regular sleep schedule
• Eating regular meals, as a drop in blood sugar can
cause headaches
• Avoiding common food triggers (chocolate, red wine,
MSG and nitrates found in many processed foods)
• Avoiding caffeine
• Exercising regularly and practicing relaxation and
stress-management techniques
• Limiting alcohol consumption
• Limiting intake of over-the-counter pain medication
Be sure to follow the directions when taking over-thecounter medications. Taking too many of some
drugs can cause something called “medication
overuse” headache.
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Local man hopes new multiple sclerosis drug gives him
his life back
George Mallet

buddies and I’m getting paid for it.”

A Washington County man has been diagnosed with
multiple sclerosis (MS), which will make his physical job
difficult and possibly impossible, but a new medication
could help maintain his quality of life.

Needless to say, Brandner would like to continue
working. He knows multiple sclerosis could well make
that impossible.

Jeff Brandner first noticed symptoms when he was at
the EAA air show last year.
“Well, initially I just started limping,” he said. “It was
rainy and dreary that day and I was limping all day long.
No pain in my leg.”
Brandner showed a glimpse of dry humor when we
asked him what he did next.
“Well, I’m a man, so I did nothing,” he said. “Then my
sister yelled at me and then I went to the doctor.”
Doctors ordered an MRI taking a close look at
Brandner’s brain and spinal cord. Lesions were
clearly visible. Doctors told Brandner he had primary
progressive multiple sclerosis. It is an insidious disease
that robs patients of many physical abilities and can
leave them wheelchair bound.
“I cried as soon as he told me,” Brandner said, referring
to the diagnosis shared by his neurologist, Dr. Akram
Dastagir of Aurora Health Care.
Brandner is only 48 years old and works in the
Washington County Highway Department. It is a
physical job characterized by lots of walking, lifting,
climbing and pounding with a jackhammer.
“I like that kind of work, physical work,” Brandner said.
“I like the guys I work with. They’re awesome. It’s like
you’re not going to work. I’m going to hang out with my

But in recent months, the FDA approved the first drug
for the treatment of primary progressive MS called
Ocrevus.
“What’s unique to Ocrevus is it’s the only approved FDA
medication for primary progressive MS,” Dastagir said.
“What’s really exciting is we have this new medication
that’s been approved and it’s been showing benefit in
clinical trials.”

In recent months, the
FDA approved the first
drug for the treatment of
primary progressive
MS called Ocrevus

Dastagir is quick to point out that Ocrevus is not a cure.
Patients with primary progressive MS have progressive
deterioration of their physical faculties, an increase in
disability. In clinical trials, Ocrevus has shown an ability
to slow that progression and decrease disability by
roughly 25 percent in patients.

Neuroscience Service Line 3000 W. Montana Street | Milwaukee, WI 53215
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